why choose us

First received: July 14, 2023

Clinical Trial: A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: A Master Protocol for the Multi-Cohort, Phase 1/2 Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Brief Summary: This is a Phase 1/2, multicenter, open-label (unless otherwise specified in a combination-specific module) study of DCC-3116 in combination with anticancer therapies.Modules within the master protocol are defined according to different combinations of DCC-3116 with other anticancer agents.

Read more